Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Discovery of novel potent and selective IRAK1 degraders

Oct. 4, 2021

Different way of looking allows new insights into cancer biology

Oct. 1, 2021

APMAP identified as a regulator of cancer cell phagocytosis

Oct. 1, 2021

PTGER4 antagonists discovered at Hubei Bio-Pharmaceutical, Humanwell Healthcare

Oct. 1, 2021

Leiden University and collaborators patent monoglyceride lipase inhibitors

Oct. 1, 2021

Compound inhibits acute myeloid leukemia cells with FLT3-ITD mutations by targeting HSP70

Oct. 1, 2021

GlaxoSmithKline compounds may illuminate TAF1 (BD2) potential as a therapeutic target

Sep. 30, 2021

ER-001259851-000, novel selective Axl inhibitor with promising PK profile in vivo

Sep. 30, 2021

New CDK12 inhibitors presented by Bayer, Deutsches Krebsforschungszentrum

Sep. 30, 2021

Ennovabio, Shanghai Ennova Biopharmaceutical patent MAP4K1 inhibitors

Sep. 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...